Entero Healthcare Solutions Share Price

Entero Healthcare Solutions Limited was incorporated as Entero Healthcare Solutions Private Limited dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, at New Delhi. Subsequently, the Company was converted into a public limited company and the name of the Company was changed to Entero Healthcare Solutions Limited, and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.The Company was founded in 2018 by Prabhat Agrawal, the Promoter to create an organized, panIndia, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. The Company is the authorized distributor for most of the top pharmaceutical companies in India. It also has strategic supply relationship with some of the leading corporate hospital chains of the country, The Companys primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India. The Company acquired 100% shareholding in Novacare Healthcare Solutions Private Limited, making it a wholly owned subsidiary in 2018. In 2022, SS Pharma Traders Private Limited was acquired by the Company, making it a wholly owned subsidiary of the Company. In 2023, Entero R.S. Enterprises Limited and Dhanvanthri Super Speciality Private Limited were acquired as 100% subsidiary of the Company. The Company came up with an IPO of issuing 12,725,244 equity shares of Rs 10 each by raising capital aggregating to Rs 1600 Cr, comprising a fresh issue of 7,955,769 equity shares of Rs 1000 Cr and offer for sale of 4,769,475 equity shares to Rs 600 Cr in February, 2024.The Company operate in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation. Subsequent to completion of an acquisition, it deploy growth strategies such as product portfolio expansion, increased customer reach, improved service levels, and technologybased solutions to increase the market share. It is providing the customers through a diverse spectrum of healthcare products, including pharmaceutical products, nutraceuticals, medical devices, surgical consumables, overthecounter medicines and vaccines.

As of 13 Jun, 2025, ENTERO share price is ₹1193.4. The stock opened at ₹1195 and had closed at ₹1197.6 the previous day. During today’s trading session, ENTERO share price moved between ₹1,185.00 and ₹1,210.00, with an average price for the day of ₹1.00. Over the last 52 weeks, the stock has recorded a low of ₹1,010.05 and a high of ₹1,584.25. In terms of performance, ENTERO share price has declined by 18.5% over the past six months and has increased by 17.23% over the last year.